Ablatus Therapeutics Limited
Company 09812865 Liquidation
Connected board network
The connection graph needs a free account.
This company's record is public. The network of who else its directors govern is compiled from the registers by us, and an account keeps it out of bulk scrapers.
Sign in, freeBoard DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Gaps to watch
- Several long-serving directors could step down together
- Narrow spread of sectors across the board
Where to look Suggested search: succession planning for long-tenured seats; directors from a wider range of sectors.
Related organisations iRelated organisationsCompanies whose board overlaps with this one through the same people. Deterministic, from public records.
- Health Enterprise East Limited 1 shared director
- PD and NJ Hayes LTD 1 shared director
- Medtech Accelerator Limited 1 shared director
- Health Tech Enterprise Limited 1 shared director
- NJ Hayes Limited 1 shared director
- Steera Advisory Limited 1 shared director
Companies whose board overlaps with this one through the same people. Deterministic, from public records.
Company details
| Number | 09812865 |
| Status | Liquidation |
| Type | Private Limited Company |
| Incorporated | 07/10/2015 |
| Address | BROOKLANDS COURT, PHASE 2 OFFICE 9, TUNSTALL ROAD, LEEDS, WEST YORKSHIRE, LS11 5HL |
| Accounts next due | 30/09/2024 |
| Accounts last made up | 31/12/2022 |
Industry (SIC)
Ownership - persons with significant control (4)
- Norfolk & Norwich University Hospital Nhs Foundation Trust ceased 2017
ownership of shares 25-50% voting rights 25-50% - Health Enterprise East Ltd ceased 2017
ownership of shares 25-50% voting rights 25-50% - Nvm Private Equity Llp ceased 2019
significant influence or control - Mercia Asset Management Plc ceased 2024
ownership of shares 25-50% as firm significant influence or control
Officers (7)
- Looi, Chung Yen, Dr Director · appointed 2022
- Hayes, Natalie Jayne, Dr Director · appointed 2020
- Flather, Marcus Denis, Professor Director · appointed 2016
- Blackwood, Anne Dunlop, Dr Director · appointed 2015
Show 3 former officers
- David Miles Lewis Director · appointed 2021 · resigned 2022
- Allan, William David, Dr Director · appointed 2016 · resigned 2021
- Brooks, David Graham, Dr Director · appointed 2015 · resigned 2020
Directors and officers on the Companies House record, current and former.
Report an error in this record - let us know.
Related record